C07D 221/24
Camphidines
C07D221/24 (Camphidines) appears on 54 US grants and 39 published applications in this corpus.
Search patents in C07D- Granted patents
- 54
- Published applications
- 39
- Assignees
- 31
- Inventors
- 193
- Latest grant
- 10 Jun 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 3 | 6 |
| 2003 | 2 | 2 |
| 2004 | 1 | 2 |
| 2005 | 3 | 1 |
| 2006 | 1 | 1 |
| 2007 | 3 | 1 |
| 2008 | 0 | 1 |
| 2009 | 1 | 5 |
| 2010 | 0 | 3 |
| 2011 | 1 | 1 |
| 2012 | 3 | 1 |
| 2013 | 3 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 2 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain10 Jun 2025US 12,325,691 B2Board of Regents, The University of Texas System
- Bicyclic RORγ modulators25 Jan 2022US 11,230,555 B2Escalier Biosciences B.V.
- Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use20 Oct 2020US 10,806,724 B2Merck Sharp & Dohme Corp.
- Compounds and methods for treating cancer, neurological disorders, ethanol withdrawal, anxiety, depression, and neuropathic pain22 Oct 2019US 10,450,275 B2Board of Regents, The University of Texas System
- Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their use2 Jul 2019US 10,335,399 B2Merck Sharp & Dohme Corp.
- C19 diterpenoid alkaloid, and preparation method and application thereof20 Feb 2025US 2025/0059140 A1Southwest Jiaotong University
- Compound as inhibitor of complement factor d, and pharmaceutical composition and use thereof28 Nov 2024US 2024/0391877 A1Wuhan Createrna Science and Technology Co., Ltd.
- Soluble Epoxide Hydrolase Inhibitors and Use Thereof5 Sep 2024US 2024/0293362 A1Board of Trustees of Michigan State University
- Chromane, isochromane and dihydroisobenzofuran derivatives as mglur2-negative allosteric modulators, compositions, and their use14 Jul 2022US 2022/0218676 A1Merck Sharp & Dohme Corp.
- Bicyclic ror-gamma modulators7 Apr 2022US 2022/0106329 A1Escalier Biosciences B.V.
Most cited
By later US patents
- Aryl fused azapolycyclic compounds52US 6,410,550 B1Pfizer Inc. · 2002
- Benzodiazepine derivatives50US 5,618,812 AMerck Sharp & Dohme Corp. · 1997
- Azepane derivatives and methods of treating hepatitis B infections45US 9,181,288 B2Novira Therapeutics, Inc. · 2015
- Amides and esters containing bridged piperidines and use as serotonin M antagonists41US 4,797,406 ASandoz Ltd. · 1989
- Sulphonamide derivatives and their use in the treatment of CNS disorders29US 6,265,408 B1SmithKline Beecham Corporation · 2001